melanomafocus.com
Specialist Committees - Melanoma Focus
http://melanomafocus.com/home-page/specialist-committees
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary - Melanoma Focus
http://melanomafocus.com/information-portal/summaries/4301-2
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Objectives - Melanoma Focus
http://melanomafocus.com/home-page/objectives
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Trustees, Management & Advisers - Melanoma Focus
http://melanomafocus.com/home-page/trustees
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Other Organisations - Melanoma Focus
http://melanomafocus.com/information-portal/melanoma-organisations-2
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
AVAST-M Trial – Patient Update - Melanoma Focus
http://melanomafocus.com/patient-support/avastm-trial-patient-update
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Weblinks - Melanoma Focus
http://melanomafocus.com/information-portal/weblinks
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Overcoming Resistance to Dabrafenib: Lay Summary - Melanoma Focus
http://melanomafocus.com/information-portal/summaries/lay-summaries
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
News - Melanoma Focus
http://melanomafocus.com/news-updates/updates
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
melanomafocus.com
Melanoma Focus Booklet - Melanoma Focus
http://melanomafocus.com/information-portal/library/new-melanoma-focus-booklet
Trustees, Management & Advisers. Information & Links. Summaries of Scientific Papers. Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary. Overcoming Resistance to Dabrafenib: Lay Summary. Funding of BRAF MEK Inhibitor Combinations. Film: Taking Part in Clinical Trials. AVAST-M Trial Patient Update. Cambridge Melanoma Support Group. Sunbeds: Misleading Claims Thwarted. Mucosal Melanoma Guidelines Project. Uveal Melanoma Guidelines Project. 2016 Regional Meeting Papers.
SOCIAL ENGAGEMENT